Vivan Therapeutics offers a groundbreaking approach to personalized cancer treatment and research through their Personal Discovery Process. With an aim to revolutionize cancer therapeutics, Vivan provides individuals with tailored treatment options on an unprecedented scale. The process involves analyzing a patient's entire exome to capture their unique tumor network, which is then engineered into a population of 500,000 fruit fly avatars.

Using robotics, Vivan screens up to 2,000 FDA/NICE approved drugs, including non-cancer drugs, to identify effective combinations specific to the patient's avatar population. Developed by the Icahn School of Medicine at Mount Sinai, the Personal Discovery Process has been refined through years of clinical research. This method allows for the identification of novel drug combinations that address resistant tumors with mutations in multiple genes.

Notably, these effective combinations often include non-cancer drugs. Vivan Therapeutics, licensed exclusively for My Personal Therapeutics, is at the forefront of personalized cancer treatment, offering patients tailored solutions and hope for improved outcomes